M1 Kliniken AG

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

D54872110
SEDOL

BYQC665
CIK

N/A

m1-kliniken.de
LEI: 529900W697S31A26WT02
FIGI: BBG00B02V2J1
M12

M1 Kliniken AG
GICS: - · Sector: - · Sub-Sector: -
NAME
M1 Kliniken AG
ISIN
DE000A0STSQ8
TICKER
M12
MIC
XETR
REUTERS
M12.DE
BLOOMBERG
M12 GR
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Tue, 19.11.2024

  M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million Beauty segment growth driver with sales +33.5% to EUR 71.02 million EBIT in the Beauty segment +30.4% to EUR 16.26 million Medium-term target c...
Fri, 06.09.2024

Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH 06.09.2024 / 14:30 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude ...
Tue, 03.09.2024

  Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024   Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million Earnings per share increased from EUR 0.17 to EUR 0.53 Beauty segment: sales +30.6% and EBIT +24.3% Profitable growth to be continued   Berlin, 03.09.2024 –...
Fri, 21.06.2024

M1 Kliniken AG: Management Board confirms growth targets Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG. Attila Strauss emphasis...
Fri, 21.06.2024

M1 Kliniken AG: Management Board confirms growth targets Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG. Attila Strauss emphasis...
Tue, 11.06.2024

 M1 Kliniken announces change in the Management Board and confirms long-term growth strategy Berlin, 11 June 2024 - Kilian Brenske, member of the Management Board since 2022, has asked the Supervisory Board to terminate his position on the Management Board for private reasons. The areas of national and international expansion, marketing, purchasin...
Thu, 06.06.2024

Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to M1 Kliniken AG Company Name: M1 Kliniken AG ISIN: DE000A0STSQ8 Reason for the research: Mid-term Guide & 2023 report & Q1 KPIs Recommendation: Kaufen from: 06.06.2024 Target price: €28 Target price on sight of: ...
Thu, 06.06.2024

Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to M1 Kliniken AG Company Name: M1 Kliniken AG ISIN: DE000A0STSQ8 Reason for the research: Mid-term Guide & 2023 report & Q1 KPIs Recommendation: Kaufen from: 06.06.2024 Target price: €28 Target price on sight of: ...
Thu, 06.06.2024

  M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024   Group sales increase by 9.6% to EUR 84.7 million in Q1 2024 Growth driver Beauty segment: sales +18.2% and EBIT +50% Strong operating performance should continue for the rest of the year   Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A...
Thu, 06.06.2024

  M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024   Group sales increase by 9.6% to EUR 84.7 million in Q1 2024 Growth driver Beauty segment: sales +18.2% and EBIT +50% Strong operating performance should continue for the rest of the year   Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements